These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17037383)

  • 41. Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.
    Cambau E; Bonnafous P; Perani E; Sougakoff W; Ji B; Jarlier V
    Clin Infect Dis; 2002 Jan; 34(1):39-45. PubMed ID: 11731943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug resistance in patients with leprosy in the United States.
    Williams DL; Lewis C; Sandoval FG; Robbins N; Keas S; Gillis TP; Scollard DM
    Clin Infect Dis; 2014 Jan; 58(1):72-3. PubMed ID: 24065328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae.
    Sapkota BR; Ranjit C; Macdonald M
    Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug-resistant leprosy: monitoring and current status.
    Williams DL; Gillis TP
    Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
    [No Abstract]   [Full Text] [Related]  

  • 48. Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae.
    Sapkota BR; Ranjit C; Neupane KD; Macdonald M
    J Med Microbiol; 2008 Feb; 57(Pt 2):179-184. PubMed ID: 18201983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular basis of rifampin resistance in Mycobacterium leprae.
    Honore N; Cole ST
    Antimicrob Agents Chemother; 1993 Mar; 37(3):414-8. PubMed ID: 8460911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A second case of multidrug-resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy.
    Matsuoka M; Kashiwabara Y; Liangfen Z; Goto M; Kitajima S
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):240-3. PubMed ID: 14608820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
    Li X; Li G; Yang J; Jin G; Shao Y; Li Y; Wei P; Zhang L
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
    Pattyn SR
    Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid test for drug resistance in leprosy.
    Ambrose EJ; Khanolkar SR; Antia NH; Chulawalla RG; Koticha KK
    Lancet; 1977 Nov; 2(8046):1036. PubMed ID: 72940
    [No Abstract]   [Full Text] [Related]  

  • 55. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
    Marijke Braet S; Jouet A; Aubry A; Van Dyck-Lippens M; Lenoir E; Assoumani Y; Baco A; Mzembaba A; Cambau E; Vasconcellos SEG; Rigouts L; Suffys PN; Hasker E; Supply P; de Jong BC
    Lancet Microbe; 2022 Sep; 3(9):e693-e700. PubMed ID: 35850123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
    Gillis TP; Williams DL
    Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
    Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
    Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
    Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
    Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM; Dimova V
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.